Dow Jones Turns Lower; F-star Therapeutics Shares Spike Higher
U.S. stocks pared gains midway through trading, with the Dow Jones dropping 100 points on Thursday.
44 Stocks Moving In Thursday’s Mid-Day Session: F-star Therapeutics, Revlon And More
Gainers
Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI’s Brain Cancer Vaccine, Xenon’s Epilepsy Candidate Shows Promise
Here's a roundup of top developments in the biotech space over the last 24 hours:
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
Gainers
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
40 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
SVB Leerink Maintains Outperform on F-star Therapeutics, Lowers Price Target to $21
SVB Leerink analyst Daina Graybosch maintains F-star Therapeutics (NASDAQ:FSTX) with a Outperform and lowers the price target from $25 to $21.
Recap: F-star Therapeutics Q1 Earnings
F-star Therapeutics (NASDAQ:FSTX) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.